These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28181923)

  • 1. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
    Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
    Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships Between Smoking Behaviors and Cotinine Levels Among Two American Indian Populations With Distinct Smoking Patterns.
    Tanner JA; Henderson JA; Buchwald D; Howard BV; Henderson PN; Tyndale RF
    Nicotine Tob Res; 2018 Mar; 20(4):466-473. PubMed ID: 28549179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
    Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF
    Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
    Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
    Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
    Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
    Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
    Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
    Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
    Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
    Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.
    Murphy SE
    Chem Res Toxicol; 2017 Jan; 30(1):410-419. PubMed ID: 28092945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
    Park SL; Tiirikainen MI; Patel YM; Wilkens LR; Stram DO; Le Marchand L; Murphy SE
    Carcinogenesis; 2016 Mar; 37(3):269-279. PubMed ID: 26818358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
    Yuan JM; Nelson HH; Carmella SG; Wang R; Kuriger-Laber J; Jin A; Adams-Haduch J; Hecht SS; Koh WP; Murphy SE
    Carcinogenesis; 2017 Apr; 38(4):411-418. PubMed ID: 28182203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine metabolism and its association with CYP2A6 genotype among Indigenous people in Alaska who smoke.
    Schaefer KR; Avey JP; Todd MR; Beans JA; Dillard DA; Shireman LM; Thornton TA; Tyndale RF; Thummel KE; Robinson RF; Claw KG
    Clin Transl Sci; 2021 Nov; 14(6):2474-2486. PubMed ID: 34520119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
    Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
    Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
    PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity.
    El-Boraie A; Taghavi T; Chenoweth MJ; Fukunaga K; Mushiroda T; Kubo M; Lerman C; Nollen NL; Benowitz NL; Tyndale RF
    Addict Biol; 2020 Jan; 25(1):e12741. PubMed ID: 30815984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
    Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
    Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
    Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
    PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations.
    El-Boraie A; Chenoweth MJ; Pouget JG; Benowitz NL; Fukunaga K; Mushiroda T; Kubo M; Nollen NL; Sanderson Cox L; Lerman C; Knight J; Tyndale RF
    Clin Pharmacol Ther; 2021 Oct; 110(4):975-985. PubMed ID: 33300144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.
    Binnington MJ; Zhu AZ; Renner CC; Lanier AP; Hatsukami DK; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2012 Jun; 22(6):429-40. PubMed ID: 22569203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.
    Fogli S; Saba A; Del Re M; Pistelli F; Aquilini F; Zucchi R; Palla A; Breschi MC; Carrozzi L; Danesi R
    J Pharm Biomed Anal; 2016 Nov; 131():208-213. PubMed ID: 27599351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of CYP2A6 Gene Polymorphism with Smoking Status Among Jordanians: Gender-Related Differences.
    Hammad HM; Imraish A; Azab B; Best AM; Khader YS; Zihlif M
    Curr Drug Metab; 2019; 20(9):765-770. PubMed ID: 31453782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.